Maria Podolak-Dawidziak
Overview
Explore the profile of Maria Podolak-Dawidziak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Podolak-Dawidziak M, Krasinski Z
Pol Arch Intern Med
. 2024 Oct;
134(10).
PMID: 39474876
No abstract available.
2.
Biernat M, Jedrzejuk D, Urbaniak-Kujda D, Biernat P, Laszkowska-Lewko M, Landwojtowicz M, et al.
Haemophilia
. 2023 Dec;
30(1):130-139.
PMID: 38082544
Introduction: In people with haemophilia (PWH), recurrent episodes of bleeding lead to joint deterioration and bone resorption. To date, the effects of various other factors on bone mineral density (BMD)...
3.
Miesbach W, Halimeh S, Platokouki H, Podolak-Dawidziak M, Zdziarska J, Korczowski B, et al.
Haemophilia
. 2023 Nov;
30(1):236-240.
PMID: 38030954
No abstract available.
4.
Podolak-Dawidziak M, Letowska M, Windyga J
Pol Arch Intern Med
. 2023 Nov;
133(11).
PMID: 37921639
No abstract available.
5.
Pulanic D, Batorova A, Bodo I, cervinek L, Ionita I, Lissitchkov T, et al.
Ann Hematol
. 2023 Feb;
102(4):715-727.
PMID: 36826482
There are currently three thrombopoietin receptor agonists (TPO-RAs) approved in Europe for treating patients with immune thrombocytopenia (ITP): romiplostim (Nplate®), eltrombopag (Revolade®), and avatrombopag (Doptelet®). However, comparative clinical data between...
6.
Podolak-Dawidziak M, Letowska M, Windyga J
Pol Arch Intern Med
. 2022 Nov;
132(11).
PMID: 36382971
No abstract available.
7.
Schmitt C, Mancuso M, Chang T, Podolak-Dawidziak M, Petry C, Sidonio Jr R, et al.
Haemophilia
. 2022 Oct;
29(1):90-99.
PMID: 36271487
Introduction: Emicizumab promotes effective haemostasis in people with haemophilia A (PwHA). It is indicated for routine prophylaxis of bleeding episodes in PwHA with or without factor (F)VIII inhibitors. Aim: To...
8.
Zdziarska J, Gorska-Kosicka M, Jamrozik M, Kozinska J, Podolak-Dawidziak M, Stefanska-Windyga E, et al.
Pol Arch Intern Med
. 2022 Aug;
132(7-8).
PMID: 35925049
Introduction: Patient adherence to a prophylactic regimen is important for optimal benefit of hemophilia treatment. Despite a growing number of adults with hemophilia in Poland receiving secondary prophylaxis, data on...
9.
Podolak-Dawidziak M, Letowska M, Windyga J
Pol Arch Intern Med
. 2021 Oct;
131(10).
PMID: 34704701
No abstract available.
10.
Sobas M, Podolak-Dawidziak M, Lewandowski K, Bator M, Wrobel T
Int J Mol Sci
. 2021 Oct;
22(20).
PMID: 34681577
This article collects several published cases in which immune thrombocytopenic purpura (ITP) is followed by essential thrombocythemia (ET) and vice versa. This surprising clinical condition is possible, but very rare...